Parama Dey, Ph.D.
Affiliations: | 2012 | Biochemistry and Molecular Biology | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Cell Biology, Molecular Biology, Biochemistry, OncologyGoogle:
"Parama Dey"Parents
Sign in to add mentor| Surinder K. Batra | grad student | 2012 | University of Nebraska Medical Center | |
| (Role of Novel Cell Cycle Regulator(s) in Pancreatic Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dey P, Wang A, Ziegler Y, et al. (2020) Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 12 |
| Karmakar S, Dey P, Vaz AP, et al. (2018) PD2/PAF1 at the Crossroads of the Cancer Network. Cancer Research |
| Vaz AP, Deb S, Rachagani S, et al. (2015) Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Oncotarget |
| Rachagani S, Macha MA, Menning MS, et al. (2015) Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget |
| Vaz AP, Ponnusamy MP, Rachagani S, et al. (2014) Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells British Journal of Cancer. 111: 486-496 |
| Dey P, Rachagani S, Vaz AP, et al. (2014) PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget. 5: 4480-91 |
| Horn A, Chakraborty S, Dey P, et al. (2013) Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Archives of Pathology & Laboratory Medicine. 137: 546-51 |
| Vaz AP, Ponnusamy MP, Rachagani S, et al. (2013) Abstract 271: Overexpression of hPaf1/PD2 in pancreatic cancer stem cells results in stemness and drug resistance: a novel target for pancreatic cancer therapy. Cancer Research. 73: 271-271 |
| Rachagani S, Torres MP, Kumar S, et al. (2012) Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Journal of Hematology & Oncology. 5: 68 |
| Dey P, Rachagani S, Chakraborty S, et al. (2012) Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6188-98 |